Multidrug resistance associated protein 1 protects against bilirubin-induced cytotoxicity

26Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

We have shown that multidrug resistance associated protein 1 (MRP1) mediates ATP-dependent extrusion of bilirubin, possibly limiting its potentially toxic accumulation in cells. To determine directly if Mrp1 protects cells against unconjugated bilirubin (UCB) toxicity, mouse embryo fibroblasts (MEF) were isolated from Mrp1 knockout (-/-) mice and their wild type (WT) (+/+) littermates. Compared to WT cells, cultured MEF (-/-) cells exposed to 40-140 nM unbound [H3]-bilirubin accumulated twice as much [H 3]-bilirubin (P < 0.01). This was associated with greater, dose-related cytotoxicity, assessed by the methylthiazoletetrazolium test, lactate dehydrogenase release and cellular ATP content. The data confirm that Mrp1 limits intracellular accumulation of UCB and thus decreases its cytotoxicity. © 2006 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Cite

CITATION STYLE

APA

Calligaris, S., Cekic, D., Roca-Burgos, L., Gerin, F., Mazzone, G., Ostrow, J. D., & Tiribelli, C. (2006). Multidrug resistance associated protein 1 protects against bilirubin-induced cytotoxicity. FEBS Letters, 580(5), 1355–1359. https://doi.org/10.1016/j.febslet.2006.01.056

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free